Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
UBS
Mallinckrodt
Daiichi Sankyo
Julphar
Covington
Dow
Fish and Richardson
Cantor Fitzgerald
Express Scripts

Generated: January 23, 2018

DrugPatentWatch Database Preview

Prednisolone acetate; sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone acetate; sulfacetamide sodium and what is the scope of prednisolone acetate; sulfacetamide sodium patent protection?

Prednisolone acetate; sulfacetamide sodium
is the generic ingredient in ten branded drugs marketed by Allergan, Alcon, Schering, Pharmafair, Novartis, Akorn, and Bausch And Lomb, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-six drug master file entries for prednisolone acetate; sulfacetamide sodium. Two suppliers are listed for this compound.
Summary for prednisolone acetate; sulfacetamide sodium
Pharmacology for prednisolone acetate; sulfacetamide sodium

US Patents and Regulatory Information for prednisolone acetate; sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 088032-001 Apr 15, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alcon CETAPRED prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087771-001 Aug 6, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering METIMYD prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 010210-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn PREDAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088059-001 Jul 29, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis VASOCIDIN prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 088791-001 Oct 5, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair PREDSULFAIR II prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088837-001 Dec 24, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088007-001 Apr 19, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan BLEPHAMIDE S.O.P. prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087748-001 Dec 3, 1986 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb SULPHRIN prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088089-001 Dec 28, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering METIMYD prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 010210-002 Sep 9, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
QuintilesIMS
Daiichi Sankyo
Chinese Patent Office
Mallinckrodt
Farmers Insurance
Merck
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot